Results 141 to 150 of about 211,431 (346)
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman +3 more
wiley +1 more source
Acute pancreatitis: current perspectives on diagnosis and management
Adarsh P Shah, Moustafa M Mourad, Simon R Bramhall Department of Surgery, Hereford County Hospital, Hereford, UK Abstract: The last two decades have seen the emergence of significant evidence that has altered certain aspects of the management ...
Shah AP, Mourad MM, Bramhall SR
doaj
Institutional Outcomes following Total Pancreatectomy and Islet Autotransplantation in Children [PDF]
Purpose: Total pancreatectomy with islet autotransplantation (TPIAT) is used to treat debilitating chronic pancreatitis (CP) and acute recurrent pancreatitis (ARP) that has failed medical and endoscopic therapy.
Sekoulopoulos, Stephen P
core +1 more source
Role of Bile Acids and Bile Salts in Acute Pancreatitis
Quang Trung Tran +13 more
openalex +1 more source
Atypical Euglycemic Ketoacidosis in a non-diabetic Patient due to acute pancreatitis [PDF]
Andree Emanuilov Manov, Ikechukwu Ogbu
openalex +1 more source

